[11] [12] Safety Considerations When Combining These Medications When taking Wegovy and bupropion together, several safety considerations should guide your treatment: Monitoring for Side Effects: Both medications have distinct side effect profiles that require attention: Wegovy : Nausea, vomiting, diarrhoea, constipation, abdominal pain, headache, fatigue, and injection site reactions
These tests indicate how well the B12 is used in the cells
If you or a loved one are age 75 or younger and took one of these medications and meet the following criteria, we want to help you : While taking a GLP-1 drug or within 30 days of stopping it, you were diagnosed with: Gastroparesis Stomach paralysis Gastric obstruction Ileus Intestinal pseudo-obstruction Intraoperative pulmonary aspiration Gallbladder removal (if exposure occurred before March 2022) You are no longer taking the GLP-1 drug that injured you You required hospital admission as a result of your drug-related injuries You were not receiving chemotherapy at or around the time of your injury In addition, were taking claims from the surviving loved ones of people who committed suicide while taking a GLP-1 agonist drug
GLP-1 medications qualify as eligible medical expenses under IRS guidelines for both HSA and FSA accounts when prescribed by a licensed clinician
Microdosing GLP-1 Receptor Agonists During Perimenopause: A Clinical Approach to Hormonal Weight Gain Written and edited by Sarah Bonza MD, MPH, FAAFP, MSCP, DipABLM, NBC-HWC Perimenopause represents a challenging time for women, with up to 70% experiencing weight gain due to declining estrogen levels, decreased energy expenditure, and metabolic changes